119 related articles for article (PubMed ID: 15193294)
1. Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model.
El-Banoua F; Caraballo I; Flores JA; Galan-Rodriguez B; Fernandez-Espejo E
Neurobiol Dis; 2004 Jul; 16(2):377-85. PubMed ID: 15193294
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
[TBL] [Abstract][Full Text] [Related]
3. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Di Marzo V; Hill MP; Bisogno T; Crossman AR; Brotchie JM
FASEB J; 2000 Jul; 14(10):1432-8. PubMed ID: 10877836
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
Ferrer B; Gorriti MA; Palomino A; Gornemann I; de Diego Y; Bermudez-Silva FJ; Bilbao A; Fernandez-Espejo E; Moratalla R; Navarro M; Rodríguez de Fonseca F
Eur J Pharmacol; 2007 Mar; 559(2-3):180-3. PubMed ID: 17291487
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal injection of D1 or D2 dopamine agonists affects glucose utilization in both the direct and indirect pathways of the rat basal ganglia.
Conti G; Blandini F; Tassorelli C; Giubilei F; Fornai F; Zocchi A; Orzi F
Neurosci Lett; 2001 Aug; 309(3):161-4. PubMed ID: 11514066
[TBL] [Abstract][Full Text] [Related]
6. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
7. Direct modulation of firing activity by dopamine D
Zhu YC; Xue Y; Diao HL; Chen H; Liu HY; Han XH; Chen L
Sheng Li Xue Bao; 2016 Oct; 68(5):699-707. PubMed ID: 27778037
[TBL] [Abstract][Full Text] [Related]
8. Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study.
Fenu S; Acquas E; Di Chiara G
Neurol Sci; 2001 Feb; 22(1):63-4. PubMed ID: 11487203
[TBL] [Abstract][Full Text] [Related]
9. D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry.
O'Neill C; Evers-Donnelly A; Nicholson D; O'Boyle KM; O'Connor JJ
J Neurochem; 2009 Feb; 108(3):545-51. PubMed ID: 19187091
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
11. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
Maneuf YP; Crossman AR; Brotchie JM
Exp Neurol; 1997 Nov; 148(1):265-70. PubMed ID: 9398468
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
13. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
Popoli P; Pèzzola A; Torvinen M; Reggio R; Pintor A; Scarchilli L; Fuxe K; Ferré S
Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164
[TBL] [Abstract][Full Text] [Related]
14. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692
[TBL] [Abstract][Full Text] [Related]
15. Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Force M; Tsou K; Miller AS; Walker JM
Synapse; 1998 Oct; 30(2):221-6. PubMed ID: 9723792
[TBL] [Abstract][Full Text] [Related]
16. Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus.
Miller AS; Sañudo-Peña MC; Walker JM
Brain Res; 1998 May; 793(1-2):7-11. PubMed ID: 9630477
[TBL] [Abstract][Full Text] [Related]
17. Decreased HCN2 expression in STN contributes to abnormal high-voltage spindles in the cortex and globus pallidus of freely moving rats.
Yang C; Zhang JR; Chen L; Ge SN; Wang JL; Yan ZQ; Jia D; Zhu JL; Gao GD
Brain Res; 2015 Aug; 1618():17-28. PubMed ID: 25998542
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry.
Muñoz-Arenas G; Paz-Bermúdez F; Báez-Cordero A; Caballero-Florán R; González-Hernández B; Florán B; Limón ID
Synapse; 2015 Mar; 69(3):103-14. PubMed ID: 25522178
[TBL] [Abstract][Full Text] [Related]
19. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models.
Kreitzer AC; Malenka RC
Nature; 2007 Feb; 445(7128):643-7. PubMed ID: 17287809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
